<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Neuropathy on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/neuropathy/</link><description>Recent content in Neuropathy on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Fri, 10 Jul 2026 05:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/neuropathy/index.xml" rel="self" type="application/rss+xml"/><item><title>Guideline: Peripheral Nervous System Manifestations in Sjögren's Disease</title><link>https://rheumatologydigest.org/posts/sjogrens-pns-guideline/</link><pubDate>Fri, 10 Jul 2026 05:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/sjogrens-pns-guideline/</guid><description>The 2026 Sjögren&amp;rsquo;s Foundation clinical practice guideline for peripheral nervous system involvement in Sjögren&amp;rsquo;s disease — an aligned neuro-rheumatology nomenclature, 31 evaluation good-practice statements, and 20 treatment recommendations (6 strong), covering mononeuropathies, polyneuropathies, and autonomic disease. Evidence is very low certainty, so most guidance rests on expert consensus.</description></item></channel></rss>